跳轉至內容
Merck
  • A new, sensitive assay to determine immunological adjuvant activity based on the immunogenicity of neuraminidase-treated sheep erythrocytes.

A new, sensitive assay to determine immunological adjuvant activity based on the immunogenicity of neuraminidase-treated sheep erythrocytes.

Methods and findings in experimental and clinical pharmacology (1986-03-01)
H van Dijk, P M Rademaker, J P Klerx, C J Beukelman, J M Willers
摘要

A novel, sensitive system to determine immunological adjuvant activity is presented. It is based on the direct haemagglutinin response of mice to neuraminidase-treated sheep red blood cells (asialo-SRBC) seven days after i.p. immunization. For two model adjuvants it is shown that the response is more sensitive to stimulation than that to normal SRBC. Optimal stimulatory activity was measured at an antigen dose of 3 x 10(6) asialo-SRBC. Using this dose stimulation indices up to 100 were observed. The minimal effective dose of dextran sulphate, the so far most potent adjuvant in the model, was only 1 microgram. It is further shown that, in addition to substances with a rather general immunostimulatory activity, compounds with adjuvanticity which is commonly restricted to cellular responses are also effective in the system. The latter and reduced activity of the model adjuvants in nude mice strongly suggest that adjuvanticity in the asialo-SRBC model is T cell-dependent. Suppression of adjuvant activity in cobra venom factor-pretreated animals may indicate an involvement of complement in extrinsic immunostimulatory activity. Results show that the asialo-SRBC model is very suitable for evaluation and mechanistic study of immunological adjuvant activity.